Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Survivorship Recommendations for Sexual and Gender Minorities

Share :

2nd ecancer Symposium on Sexual and Gender Minorities

28 Jun 2023
Published: 28 Jun 2023
Views: 17
Rating:
Save
Dr Ashwin Mehta - Memorial Healthcare System, Hollywood, FL, USA

Related Videos

The Vietnam National Cancer Institute’s efforts in improving cancer care in...
Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam ( Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute )
5 Sep 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023
The role of provider assumptions in decreasing access to care in the LGBTQ...
Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA
The role of provider assumptions in decreasing access to care in the LGBTQ community ( Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA )
28 Jun 2023
Cancer and Suicide Risk in SGM Population
Dr Gadoberto Solano - Caja Costarricense del Seguro Social, Costa Rica
Cancer and Suicide Risk in SGM Population ( Dr Gadoberto Solano - Caja Costarricense del Seguro Social, Costa Rica )
28 Jun 2023
Time toxicity: the burden on cancer patients
Dr Arjun Gupta - University of Minnesota, Minneapolis, USA
Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )
24 May 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast...
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )
2 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
VT3989 is safe and well tolerated in patients with advanced malignant...
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023
Redefining cancer research priorities in the emerging context of the COVID-19...
Prof Richard Sullivan - King's College London, London, UK
Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )
22 Nov 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation